SEC Form 4 · accession 0001140361-16-061983
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Trowbridge
Officer — SVP and General Counsel
Period of report
Apr 21, 2016
Accepted (ET)
Apr 25, 2016 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 21, 2016 | S | 10,500 | $12.33 | D | 32,469 | D | |
| Common Stock | Apr 25, 2016 | S | 2,440 | $12.18 | D | 30,029 | D | |
| Common StockF2 | Apr 25, 2016 | F | 1,358 | $12.23 | D | 28,671 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.33 to $12.34, inclusive. The reporting person undertakes to provide to AngioDynamics, Inc., any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The exempt disposition of 1,358 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on April 24, 2015.